Ioannis Panagopoulos1, Kristin Andersen2, Ludmila Gorunova2, Martine Eilert-Olsen2, Marius Lund-Iversen3, Trygve Wessel-Aas4, Isabel Lloret5, Francesca Micci2, Sverre Heim2. 1. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway; ioannis.panagopoulos@rr-research.no. 2. Section for Cancer Cytogenetics, Institute for Cancer Genetics and Informatics, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 3. Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway. 4. Division of Orthopaedic Surgery, Oslo University Hospital, Oslo, Norway. 5. Department of Radiology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway.
Abstract
BACKGROUND/AIM: Hoffa's disease is anterior knee pain presumably stemming from inflammatory fibrous hyperplasia of the infrapatellar fat pad (Hoffa's pad). The etiology and pathogenesis are unclear, however, and no genetic information about the disease has been published. We report the genetic findings in cells from the fat pad of a patient with Hoffa's disease. MATERIALS AND METHODS: Infrapatellar fat pad cells from a patient with Hoffa's disease were examined using cytogenetic, RNA sequencing, reverse transcription-polymerase chain reaction, and Sanger sequencing techniques. RESULTS: Cytogenetic examination of short-term cultured cells from the Hoffa's pad revealed a balanced t(12;18)(q14;q21) translocation as the sole chromosomal aberration. RNA sequencing detected an out-of-frame fusion of exon 3 of the gene coding for high mobility group AT-hook 2 (HMGA2) with exon 9 of the gene coding for WNT inhibitory factor 1 (WIF1). The fusion was subsequently verified by reverse transcription-polymerase chain reaction together with Sanger sequencing. CONCLUSION: Our data indicate that Hoffa's disease is a neoplastic process with acquired genetic aberrations similar to those found in many benign tumors of connective tissues. The genetic aberrations are presumably acquired by mesenchymal stem cells of the infrapatellar fat pad inducing proliferation and differentiation into adipocytes or other mature connective tissue cells. Copyright
BACKGROUND/AIM: Hoffa's disease is anterior knee pain presumably stemming from inflammatory fibrous hyperplasia of the infrapatellar fat pad (Hoffa's pad). The etiology and pathogenesis are unclear, however, and no genetic information about the disease has been published. We report the genetic findings in cells from the fat pad of a patient with Hoffa's disease. MATERIALS AND METHODS: Infrapatellar fat pad cells from a patient with Hoffa's disease were examined using cytogenetic, RNA sequencing, reverse transcription-polymerase chain reaction, and Sanger sequencing techniques. RESULTS: Cytogenetic examination of short-term cultured cells from the Hoffa's pad revealed a balanced t(12;18)(q14;q21) translocation as the sole chromosomal aberration. RNA sequencing detected an out-of-frame fusion of exon 3 of the gene coding for high mobility group AT-hook 2 (HMGA2) with exon 9 of the gene coding for WNT inhibitory factor 1 (WIF1). The fusion was subsequently verified by reverse transcription-polymerase chain reaction together with Sanger sequencing. CONCLUSION: Our data indicate that Hoffa's disease is a neoplastic process with acquired genetic aberrations similar to those found in many benign tumors of connective tissues. The genetic aberrations are presumably acquired by mesenchymal stem cells of the infrapatellar fat pad inducing proliferation and differentiation into adipocytes or other mature connective tissue cells. Copyright
Authors: Joanna M Stephen; Ran Sopher; Sebastian Tullie; Andrew A Amis; Simon Ball; Andy Williams Journal: Knee Surg Sports Traumatol Arthrosc Date: 2018-04-20 Impact factor: 4.342
Authors: M Fedele; M T Berlingieri; S Scala; L Chiariotti; G Viglietto; V Rippel; J Bullerdiek; M Santoro; A Fusco Journal: Oncogene Date: 1998-07-30 Impact factor: 9.867
Authors: Monica Fedele; Sabrina Battista; Lawrence Kenyon; Gustavo Baldassarre; Vincenzo Fidanza; Andres J P Klein-Szanto; A F Parlow; Rosa Visone; Giovanna M Pierantoni; Eric Outwater; Massimo Santoro; Carlo M Croce; Alfredo Fusco Journal: Oncogene Date: 2002-05-09 Impact factor: 9.867
Authors: Zhizhong Li; Jason A Gilbert; Yunyu Zhang; Minsi Zhang; Qiong Qiu; Krishnan Ramanujan; Tea Shavlakadze; John K Eash; Annarita Scaramozza; Matthew M Goddeeris; David G Kirsch; Kevin P Campbell; Andrew S Brack; David J Glass Journal: Dev Cell Date: 2012-11-21 Impact factor: 12.270
Authors: Fresia Pareja; Felipe C Geyer; David N Brown; Ana P Martins Sebastião; Rodrigo Gularte-Mérida; Anqi Li; Marcia Edelweiss; Arnaud Da Cruz Paula; Pier Selenica; Hannah Y Wen; Achim A Jungbluth; Zsuzsanna Varga; Juan Palazzo; Brian P Rubin; Ian O Ellis; Edi Brogi; Emad A Rakha; Britta Weigelt; Jorge S Reis-Filho Journal: NPJ Breast Cancer Date: 2019-01-18